突变K—ras基因在胰腺导管腺癌起始过程中的作用
被引量:2
摘要
胰腺导管腺癌(PDAC)是高度恶性肿瘤,其发生包括时间和空间上基因突变的积累和环境因素的影响。一般认为,PDAC的发生是由胰腺上皮内瘤变(PanlN)逐步向原位癌及浸润性导管癌发展。病变形成过程中,K—ras基因突变被认为是起始的重要分子事件,突变率达95%以上㈨,且早在PanlN1A/B病变中K-ras基因突变率即可达40%。
出处
《中华病理学杂志》
CAS
CSCD
北大核心
2012年第1期62-65,共4页
Chinese Journal of Pathology
基金
国家自然科学基金f30973470)
参考文献40
-
1Tuveson DA, Hingorani SR. Ductal pancreatic cancer in humans and mice. Cold Spring Harb Symp Quant Biol, 2005, 70 : 65-72.
-
2Luttges J, Schlehe B, Menke MA, et al. The K-ras mutation pattern in pancreatic ductal adenocarcinoma usually is identical to that in associated normal, hyperplastic, and metaplastic ductal epithelium. Cancer, 1999, 85(8): 1703-1710.
-
3Lohr M, Kloppel G, Maisonneuve P, et al. Frequency of K-ras mutations in pancreatic intraductal neoplasias associated with pancreatic ductal adenocarcinoma and chronic pancreatitis : a meta-analysis. Neoplasia, 2005, 7( 1 ): 17-23.
-
4Guerra C, Collado M, Navas C, et al. Pancreatitis-induced inflammation contributes to pancreatic cancer by inhibiting oncogene-induced senescence. Cancer Cell, 2011, 19 ( 6 ) : 728 -739.
-
5Vakkila J, Lotze MT. Inflammation and necrosis promote tumour growth. Nat Rev Immunol, 2004, 4(8) : 641-648.
-
6Tada M, Ohashi M, Shiratori Y, et al. Analysis of K-ras gene mutation in hyperplastic duct cells of the pancreas without pancreatic disease. Gastroenterology, 1996, 110( 1 ) :227-231.
-
7Sparmann A, Bar-Sagi D. Ras-induced interleukin-8 expression plays a critical role in tumor growth and angiogenesis. Cancer Cell, 2004, 6(5): 447-458.
-
8Guerra C, Schuhmacher A J, Canamero M, et al. Chronic pancreatitis is essential for induction of pancreatic ductal adenocarcinoma by K-Ras oncogenes in adult mice. Cancer Cell, 2007,11 ( 3 ) :291-302.
-
9Habbe N, Shi G, Meguid RA, et al. Spontaneous induction of murine pancreatic intraepithelial neoplasia (mPanlN) by acinar cell targeting of oncogenic Kras in adult mice. Proc Natl Acad Sci U S A, 2008,105(48) :18913-18918.
-
10Logsdon CD, Ji B. Ras activity in acinar cells links chronic pancreatitis and pancreatic cancer. Clin Gastroenterol Hepatol, 2009, 7 ( 11 Suppl) : S40-43.
同被引文献31
-
1俞松,刘文英,唐耘熳,魏艇.血管瘤裸鼠移植模型生物学特性的动态观察[J].中华小儿外科杂志,2005,26(5):264-267. 被引量:10
-
2柯少波,陕声国,周启星,孙文涛,刘旋.P21ras、FasL在皮肤血管瘤组织中的表达及意义[J].武汉大学学报(医学版),2008,29(1):51-54. 被引量:2
-
3Arbiser JL, Weiss SW, Arbiser ZK, et al. Differential expression of active mitogen-activated protein kinase incutaneous endothelial neoplasms: implications for biologic behavior and response to therapy[J]. J Am Acad Dermatol, 2001, 44(2) : 193-197.
-
4Gundel Rtt, Wegner CD, Torcellini CA, et al. The role of intercellular adhesion molecule-1 in chronic airway inflammation[J]. Clin Exp Allergy,2012,22(5):569-575.
-
5Lancaster JM,Sayer R,Blanchette C, et al. High expression of tumor necrosis factor-related apoptosis-inducing ligand is associated with favorable ovarian cancer survival [J].Clin CancerRes, 2013,9 (2) : 762-766.
-
6Johnson TR, Khandrika L, Kumar B, et al. Focal adhesion kinase controls aggressive phenotype of androgen-independent prostate cance[J].Mol Cancer Res, 2008,6 (10) : 1639-1648.
-
7Pelaia G, Gallelli L, Renda T, et al. Effects of statins and farnesyl transferase inhibitors on ERK phosphorylation, apoptosis and cell viability in non-small lung cancer cells[J]. Cell Prolif,2012,45(6) :557-565.
-
8Tang B, Reardon W, Black GC, et al. Congenital ulcerating hemangioma in a baby with KRAS mutation and cardio-facio- cutaneous syndrome[J]. Clin Dysmorphol, 2007, 16 (3) : 203- 206.
-
9郭秀娟,沈莉.痰标本p16基因启动子区甲基化联合血清细胞角蛋白19片段和癌抗原15-3对非小细胞肺癌的诊断价值[J].临床荟萃,2008,23(15):1067-1070. 被引量:4
-
10徐向明,张国良,李敏伟,王丹阳,林建江.结直肠癌组织中K-ras基因的检测及其意义[J].中华医学杂志,2010,90(18):1268-1271. 被引量:8
引证文献2
-
1刘广伟,张再兴,戴建军.ras基因在肿瘤发生、发展及诊断中的作用研究进展[J].山东医药,2014,54(27):93-95. 被引量:10
-
2徐艳朋,俞松,彭岗,王健,唐诗鹏,罗宇.Raf-1和p-ERK在血管瘤裸鼠移植模型中的表达及意义[J].中华小儿外科杂志,2015,36(12):936-939. 被引量:4
二级引证文献14
-
1闰陶然,俞松,李堂江,徐艳朋,赵兴,苏凯.PI3K/Akt/mTOR信号通路抑制剂对体外培养血管瘤内皮细胞的影响[J].中华小儿外科杂志,2018,39(11):835-840. 被引量:9
-
2张建立,马金海,崔伟,杨永滨.γ-tubulin、HER-2和k-ras在乳腺癌组织中的表达及临床意义[J].解放军医药杂志,2016,28(7):47-50. 被引量:2
-
3许晓跃,陈水平,陈建魁.恶性肿瘤治疗药物相关个体化检测研究进展[J].标记免疫分析与临床,2016,23(10):1226-1232. 被引量:2
-
4蔡琴,王杰.Raf激酶抑制蛋白启动子甲基化与肺癌患者预后的关系[J].现代肿瘤医学,2016,24(24):3941-3944. 被引量:2
-
5石毅琼,瞿既,王昕钰,李兰兰,任建功.桥本甲状腺炎合并乳头状甲状腺癌患者RAS、Gal-3和CK-19的表达及临床意义[J].内科,2017,12(2):161-163. 被引量:5
-
6李娟,俞松.AMPK/mTOR信号通路在肿瘤中的研究现状[J].安徽医药,2017,21(6):975-978. 被引量:9
-
7赵跃,吴冰杰,王朵朵,刘春蓉,孙甲甲,周广磊,黄景昊,吴凤云.基于TCGA数据库分析BRAF^(V600E)和RAS基因突变与甲状腺乳头状癌临床病理特征的相关性[J].海南医学院学报,2019,25(1):1-4. 被引量:5
-
8吴军军,张莉,蒋邦红,霍继武,宋培军.内皮祖细胞在裸鼠体内再现人血管瘤的生物学特性研究[J].蚌埠医学院学报,2019,44(5):566-569.
-
9陈继欣,吴万垠.肺衰老与肺癌[J].老年医学与保健,2019,25(6):697-700. 被引量:1
-
10谢平,张世昌,郑江.膀胱癌相关肿瘤标志物的研究进展与临床应用[J].医学理论与实践,2020,33(7):1071-1072. 被引量:7
-
1王伟,李兆申.胰腺导管腺癌小鼠模型的研究进展[J].第二军医大学学报,2008,29(4):435-438.
-
2邹金艳,商建,易三凤,伍威,林军.舒林酸对人胰腺癌细胞PANC1增殖凋亡及Wnt通路的影响[J].中华胰腺病杂志,2014,14(1):49-51. 被引量:2
-
3朱兰,王立夫.胰腺上皮内瘤变研究进展[J].胃肠病学,2011,16(2):122-124.
-
4齐晓光(综述),王立夫(审校).Hedgehog信号通路在胰腺上皮内瘤变恶性转化中的作用[J].胃肠病学,2009,14(5):303-306. 被引量:2
-
5郑建明,朱明华,倪灿荣,于观贞,刘晓红,林万和,龚志锦.E-钙黏附素和β-连环素在胰腺上皮内瘤变和胰腺癌组织中的表达[J].世界华人消化杂志,2004,12(11):2633-2637. 被引量:1
-
6郑建明,朱明华,林万和,龚志锦,刘晓红.胰腺导管腺癌、慢性胰腺炎及正常胰腺组织中胰腺上皮内瘤变的比较研究[J].胰腺病学,2004,4(3):150-153. 被引量:1
-
7祝鹏,刘慧颖,金凯舟,胡志前,王伟军.黏蛋白4在胰腺上皮内瘤变和胰腺癌中的表达差异性分析[J].临床肿瘤学杂志,2014,19(10):891-895.
-
8赵峰,周清华,陆燕蓉,张洁,王建军.突变k-ras基因修饰的树突状细胞疫苗的抗肿瘤作用[J].中华实验外科杂志,2005,22(10):1229-1230. 被引量:6
-
9苏震东,骆明德.K-ras基因突变在胰腺癌中的作用研究进展[J].国外医学(消化系疾病分册),2005,25(1):48-51. 被引量:4
-
10郑建明,朱明华.胰腺上皮内瘤变[J].胰腺病学,2004,4(2):116-120. 被引量:8